FLOGOPROFEN

This brand name is authorized in Spain, Hong Kong, Malta

Active ingredients

The drug FLOGOPROFEN contains one active pharmaceutical ingredient (API):

1 Etofenamate UNII KZF0XM66JC - ETOFENAMATE

Etofenamate is a flufenamic acid derivative, which is readily transported through the skin and concentrated in inflamed tissue, where it exerts anti-inflammatory and analgesic effects by inhibiting the release of histamine, lysosomal enzymes and prostaglandin. Read about Etofenamate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
FLOGOPROFEN Gel / Cutaneous spray solution	Medicines Authority (MT)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M02AA06	Etofenamate	M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AA Antiinflammatory preparations, non-steroids for topical use
Discover more medicines within M02AA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 55380, 55701
Country: HK	Department of Health Drug Office	Identifier(s): 52785, 53359
Country: MT	Medicines Authority	Identifier(s): MA129/00201, MA129/00202